Association Between Pulse Wave Velocity and Frailty, Disability, and Mortality in Community-Dwelling Older Adults

dc.contributor.affiliationInstituto de Salud Carlos III
dc.contributor.affiliationHospital Universitario de Getafe
dc.contributor.affiliationComplutense University of Madrid
dc.contributor.affiliationUniversidad de Las Americas - Chile
dc.contributor.affiliationComplejo Hospitalario de Toledo
dc.contributor.authorAlvarez-Bustos, Alejandro
dc.contributor.authorCarnicero, Jose A.
dc.contributor.authorRodriguez-Sanchez, Beatriz
dc.contributor.authorEl-Assar, Mariam
dc.contributor.authorRueda, Ricardo
dc.contributor.authorPereira, Suzette L.
dc.contributor.authorSepulveda-Loyola, Walter
dc.contributor.authorGarcia-Garcia, Francisco J.
dc.contributor.authorSulo, Suela
dc.contributor.authorRodriguez-Manas, Leocadio
dc.date.accessioned2024-09-03T19:20:29Z
dc.date.available2024-09-03T19:20:29Z
dc.date.issued2023-07
dc.description.abstractBACKGROUND Arterial stiffness leads to several adverse events in the older population, but there is a lack of data on its association with frailty, disability, and mortality in the same population. OBJECTIVES The purpose of this study was to evaluate the role of arterial stiffness in the loss of functional ability (frailty and disability) and mortality. METHODS Data were taken from community-dwelling aged 65 years participants without diabetes in the Toledo Study of Healthy Ageing cohort. Pulse wave velocity (PWV), assessed through SphygmoCor, was recorded at baseline. Median followup time were 2.99 years for frailty (frailty phenotype [FP] and Frailty Trait Scale-5 [FTS5]) and disability (Katz Index) and 6.2 for mortality. Logistic regressions models were built for disability and frailty and Cox proportional hazards model for death, adjusted by age and sex, comorbidity, cardiovascular risk factors, asymmetric dimethylarginine levels, and polypharmacy. RESULTS Overall, 978 (mean age 74.5 f 5.6 years, 56.7% female) participants were included. Different cut-off points were shown for each outcome. PWV >11.5 m/s was cross-sectionally associated with frailty (FP: OR fully-adjusted model: 1.69,95% CI: 1.45-1.97; FTS5: OR: 1.51, 95% CI: 1.22-1.87) and disability (OR: 1.51, 95% CI: 1.26-1.79); PWV >10 m/s with incident frailty by FP (OR: 1.36, 95% CI: 1.10-1.68) and FTS5 (OR: 1.40, 95% CI: 1.12-1.75), and PWV >11 m/s with death (HR: 1.28, 95% CI: 1.09-1.50). For incident (OR: 1.28, 95% CI: 1.06-1.55) and worsening disability (OR: 1.21, 95% CI: 1.02-1.45) the threshold was 12.5 m/s. Below these cut-off points, age was the best predictor of adverse outcomes. CONCLUSIONS Arterial stiffness predicts frailty, disability, and mortality in older people, with different cut-off points, ie,severity degrees, for each of the assessed outcomes.
dc.description.sponsorshipAbbott - Spanish Ministry of Economy, Industry and Competitiveness; European Regional Development Funds (Instituto de Salud Carlos III) [PI20/009 77]; Innovative Medicines Initiative Joint Undertaking [11562 1]; European Union; EFPIA companies; Centro de Investigacion Biomedica en Red en Fragilidad y Envejecimiento Saludable [CB16/10/00464]; Financial support for this analysis was provided by Abbott. TSHA research was funded by grants from the Spanish Ministry of Economy, Industry and Competitiveness, cofinanced by the European Regional Development Funds (Instituto de Salud Carlos III, PI20/009 77) and the Centro de Investigacion Biomedica en Red en Fragilidad y Envejecimiento Saludable (CB16/10/00464) ; the MITOFUN Project, Fundacion Francisco Soria Melguizo (Section 2/2020) ; Innovative Medicines Initiative Joint Undertaking under grant agreement np 11562 1, resources of which are composed of financial contribution from the European Union' Seventh Framework Programme (FP7/2007-2013) and EFPIA companies. Drs Rueda, Pereira, Sul o are employees of Abbott. Dr Rodriguez-Maras has received funds as a speaker in Abbott-supported conferences. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
dc.format.mimetypeapplication/pdf
dc.identifier.citationJACC: Advances, 2(5), 100423. https://doi.org/10.1016/j.jacadv.2023.100423
dc.identifier.doihttps://doi.org/10.1016/j.jacadv.2023.100423
dc.identifier.issn2772-963X
dc.identifier.orcidhttps://orcid.org/0000-0003-3690-6069
dc.identifier.orcidhttps://orcid.org/0000-0002-5537-9201
dc.identifier.orcidhttps://orcid.org/0000-0002-3431-7204
dc.identifier.orcidhttps://orcid.org/0000-0002-6146-068X
dc.identifier.pmid38939008
dc.identifier.researcheridR-9258-2017
dc.identifier.researcheridG-7400-2018
dc.identifier.researcheridGYU-8290-2022
dc.identifier.researcheridAFL-1127-2022
dc.identifier.rorhttps://ror.org/00ca2c886
dc.identifier.rorhttps://ror.org/04j0sev46
dc.identifier.rorhttps://ror.org/01ehe5s81
dc.identifier.rorhttps://ror.org/02p0gd045
dc.identifier.rorhttps://ror.org/01w8r0j67
dc.identifier.rorhttps://ror.org/0052svj16
dc.identifier.rorhttps://ror.org/00p99t114
dc.identifier.rorhttps://ror.org/0166e9x11
dc.identifier.rorhttps://ror.org/00kxqbw45
dc.identifier.scopusauthorid57201487862
dc.identifier.scopusauthorid57205090636
dc.identifier.scopusauthorid57189626078
dc.identifier.scopusauthorid11240850700
dc.identifier.scopusauthorid7004295136
dc.identifier.scopusauthorid7202024688
dc.identifier.scopusauthorid58289745600
dc.identifier.scopusauthorid57199662920
dc.identifier.scopusauthorid55367700400
dc.identifier.scopusauthorid7004685679
dc.identifier.urihttps://repositorio.udla.cl/handle/udla/1501
dc.language.isoeng
dc.publisherElsevier BV
dc.relation.fundingFundación Francisco Soria Melguizo
dc.relation.fundingAbbott Laboratories
dc.relation.fundingSeventh Framework Programme, FP7
dc.relation.fundingCentro de Investigación Biomédica en Red Fragilidad y Envejecimiento Saludable, CIBERFES, (CB16/10/00464)
dc.relation.fundingCentro de Investigación Biomédica en Red Fragilidad y Envejecimiento Saludable, CIBERFES
dc.relation.fundingEuropean Federation of Pharmaceutical Industries and Associations, EFPIA
dc.relation.fundingInstituto de Salud Carlos III, ISCIII, (PI20/00977)
dc.relation.fundingInstituto de Salud Carlos III, ISCIII
dc.relation.fundingEuropean Regional Development Fund, ERDF
dc.relation.fundingMinisterio de Asuntos Económicos y Transformación Digital, Gobierno de España, MINECO
dc.relation.fundingInnovative Medicines Initiative, IMI, (115621)
dc.relation.fundingInnovative Medicines Initiative, IMI
dc.relation.fundingAbbott - Spanish Ministry of Economy, Industry and Competitiveness
dc.relation.fundingEuropean Regional Development Funds (Instituto de Salud Carlos III) [PI20/009 77]
dc.relation.fundingInnovative Medicines Initiative Joint Undertaking [11562 1]
dc.relation.fundingEuropean Union
dc.relation.fundingEFPIA companies
dc.relation.fundingCentro de Investigacion Biomedica en Red en Fragilidad y Envejecimiento Saludable [CB16/10/00464]
dc.relation.isindexedbyWeb of Science
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttps://www.elsevier.com/tdm/userlicense/1.0/
dc.sourceJACC: Advances
dc.source.urihttps://www.sciencedirect.com/science/article/pii/S2772963X2300282X
dc.subjectdisability
dc.subjectfrailty
dc.subjectmortality
dc.subjectolder adults
dc.subjectpulse wave velocity (PWV)
dc.subject.lcshMortalidad
dc.subject.lcshAncianos
dc.subject.oecd13 Ciencias Médicas y de la Salud
dc.subject.oecd23.2 Medicina Clínica
dc.subject.oecd33.2.4 Sistema Cardiovascular y Cardíaco
dc.titleAssociation Between Pulse Wave Velocity and Frailty, Disability, and Mortality in Community-Dwelling Older Adults
dc.title.alternativeAssociation Between Pulse Wave Velocity and Frailty, Disability, and Mortality in Community-Dwelling Older Adults.
dc.typejournal article
dc.type.coarhttp://purl.org/coar/resource_type/c_6501
dc.type.driverinfo:eu-repo/semantics/article
dc.udla.catalogadorCBM
oaire.citation.issue5
oaire.citation.titleJACC: Advances
oaire.citation.volume2
udla.curacion.controljmvg
udla.oecd.area3 Ciencias Médicas y de la Salud
udla.oecd.discipline3.2.4 Sistema Cardiovascular y Cardíaco
udla.oecd.subarea3.2 Medicina Clínica

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
186.pdf
Size:
1.18 MB
Format:
Adobe Portable Document Format

Collections